Cladribine‐related myelodysplastic syndrome in Langerhans cell histiocytosis-Reference-Cited by-同舟云学术

Cladribine‐related myelodysplastic syndrome in Langerhans cell histiocytosis

Published:2019-04 Issue:4 Volume:61 Page:419-421
ISSN:1328-8067
Container-title:Pediatrics International
language:en
Short-container-title:Pediatrics International

Author:

Oh Yukiko¹,Hayase Tomomi¹,Ito Takane¹,Kawahara Yuta¹,Morimoto Akira¹^ORCID

Affiliation:

1. Department of Pediatrics Jichi Medical University School of Medicine Shimotsuke Tochigi Japan

Publisher

Wiley

Subject

Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ped.13792

Reference5 articles.

1. Recent advances in Langerhans cell histiocytosis

2. 2′-chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the histiocyte society

3. Occurrence of a myelodysplastic syndrome (MDS) during first‐line 2‐chloro‐deoxyadenosine (2‐CDA) treatment of a low‐grade gastrointestinal MALT lymphoma. Case report and review of the literature;Jäger G;Haematologica,2004

4. Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study

5. Spontaneous remission of 2-chlorodeoxyadenosine (2-CdA)-related secondary myelodysplastic syndrome in a patient with refractory Langerhans cell histiocytosis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic stem cell transplantation for Langerhans cell histiocytosis: clinical findings and long-term outcomes;Expert Opinion on Orphan Drugs;2020-06-24

2. Cladribine;Reactions Weekly;2019-05